Cargando…
Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines
INTRODUCTION: Diarrhea is a leading cause of mortality worldwide and rotavirus accounts for many of these deaths. As of August 2018, 96 countries have introduced rotavirus vaccines into their immunization programs. Two rotavirus vaccines, Rotarix® and RotaTeq®, have been WHO-prequalified since 2009,...
Autores principales: | Pecenka, Clint, Debellut, Frederic, Bar-Zeev, Naor, Anwari, Palwasha, Nonvignon, Justice, Shamsuzzaman, Md, Clark, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238205/ https://www.ncbi.nlm.nih.gov/pubmed/30420039 http://dx.doi.org/10.1016/j.vaccine.2018.10.068 |
Ejemplares similares
-
Cost-effectiveness analysis for rotavirus vaccine decision-making: How can we best inform evolving and complex choices in vaccine product selection?
por: Pecenka, Clint, et al.
Publicado: (2020) -
Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan
por: Anwari, Palwasha, et al.
Publicado: (2018) -
Rotavirus vaccine product switch in Ghana: An assessment of service delivery costs, switching costs, and cost-effectiveness
por: Owusu, Richmond, et al.
Publicado: (2023) -
Impact and cost-effectiveness of rotavirus vaccination in Bangladesh
por: Pecenka, Clint, et al.
Publicado: (2017) -
Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031
por: Nonvignon, Justice, et al.
Publicado: (2018)